Oxford BioDynamics (OBD) Competitors

Oxford BioDynamics (LON:OBD) and Tissue Regenix Group (LON:TRX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.

Does the MarketBeat Community believe in OBD or TRX?

Tissue Regenix Group received 58 more outperform votes than Oxford BioDynamics when rated by MarketBeat users. Likewise, 69.53% of users gave Tissue Regenix Group an outperform vote while only 60.82% of users gave Oxford BioDynamics an outperform vote.

Company	Underperform	Outperform
Oxford BioDynamics	Outperform Votes 104 60.82%	Underperform Votes 67 39.18%
Tissue Regenix Group	Outperform Votes 162 69.53%	Underperform Votes 71 30.47%

Do institutionals & insiders have more ownership in OBD or TRX?

44.4% of Oxford BioDynamics shares are owned by institutional investors. Comparatively, 37.0% of Tissue Regenix Group shares are owned by institutional investors. 13.4% of Oxford BioDynamics shares are owned by company insiders. Comparatively, 47.2% of Tissue Regenix Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts rate OBD or TRX?

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oxford BioDynamics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Tissue Regenix Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Is OBD or TRX more profitable?

Oxford BioDynamics has a net margin of 0.00% compared to Tissue Regenix Group's net margin of -3.46%. Tissue Regenix Group's return on equity of -3.31% beat Oxford BioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oxford BioDynamics	N/A	-266.70%	-56.23%
Tissue Regenix Group	-3.46%	-3.31%	0.50%

Which has better valuation and earnings, OBD or TRX?

Tissue Regenix Group has higher revenue and earnings than Oxford BioDynamics. Tissue Regenix Group is trading at a lower price-to-earnings ratio than Oxford BioDynamics, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oxford BioDynamics	£176K	64.85	-£11.11M	-£0.06	-61.00
Tissue Regenix Group	£31.80M	1.21	-£1.10M	-£0.01	-5,400.00

Does the media favor OBD or TRX?

In the previous week, Oxford BioDynamics' average media sentiment score of 0.00 equaled Tissue Regenix Group'saverage media sentiment score.

Company	Overall Sentiment
Oxford BioDynamics	Neutral
Tissue Regenix Group	Neutral

Which has more volatility and risk, OBD or TRX?

Oxford BioDynamics has a beta of 0.42, suggesting that its stock price is 58% less volatile than the S&P 500. Comparatively, Tissue Regenix Group has a beta of 1.61, suggesting that its stock price is 61% more volatile than the S&P 500.

Summary

Tissue Regenix Group beats Oxford BioDynamics on 9 of the 13 factors compared between the two stocks.